US approves Regeneron's antibody treatment for Ebola
Washington (AFP) - The United States on Wednesday approved a lab-made antibody treatment against the Ebola virus developed by the biotech firm Regeneron after it was shown to significantly reduce the mortality rate in a clinical trial.The drug was developed using the same technology platform that the company used to produce its experimental therapy against Covid-19, which President Donald Trump received after contracting the coronavirus. Food and Drug Administration (FDA) Commissioner Stephen Hahn said: "Today's action demonstrates the FDA's ongoing commitment to responding to public health th...